| Literature DB >> 35434135 |
Jingjing Gao1, Rui Gao1, Xi Liu1, Chengfu Li2, Pan Gao1, Junhua Du1, Xiansheng Zhang1.
Abstract
Although the personality traits (PT), patient-reported outcome (PRO), and chronic prostatitis (CP) symptoms in premature ejaculation (PE) have been evaluated, there was no study to assess their correlations in men with different PE syndromes. The purpose of this study was to assess the correlations between the PT, PRO, and CP symptoms in men with different PE syndromes. Between January 2019 and January 2021, a cross-sectional field study was conducted in our andrology clinic. Men with the complaints of PE were divided into lifelong PE (LPE), acquired PE (APE), variable PE (VPE), and subjective PE (SPE). All subjects were required to complete a verbal questionnaire with the PRO, National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), and Temperament and Character Inventory (TCI-R). Finally, 479 men with the complaints of PE and 365 without the complaints of PE were enrolled. The incidence of PE syndromes in PE complaint group was as follows: LPE 16.70%, APE 48.85%, VPE 11.27%, and SPE 23.17%. Mean ages in PE complaint group were 42.53 ± 12.25 years. In the PE complaint group, the novelty seeking (NS) scores were strongest correlated with the personal distress and quality of life (QOL). The harm avoidance (HA) scores were strongest correlated with the severity of PE and pain syndromes. The self-transcendence (ST) scores were strongest correlated with the satisfaction with sexual intercourse and QOL. In addition, strongest association between the total scores of NIH-CPSI and the NS or ST scores was also found in the APE group. The HA scores were also strongest correlated with the total scores of NIH-CPSI in SPE. Strongest association between the total scores of NIH-CPSI and the NS/TI or ST/CI scores was also found in the APE group. The HA/TI scores were also strongest correlated with the total scores of NIH-CPSI in SPE.Entities:
Mesh:
Year: 2022 PMID: 35434135 PMCID: PMC9012653 DOI: 10.1155/2022/8049976
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Classification and definition of premature ejaculation.
Figure 2The Chinese version of PRO questionnaire.
Demographic information and presence of comorbidities in men with different PE syndromes.
| Factors | Total | PE complaint | No PE complaint |
| Four PE syndromes |
| |||
|---|---|---|---|---|---|---|---|---|---|
| LPE | APE | VPE | SPE | ||||||
|
| 844 | 479 (56.75%) | 365 (43.25%) | NA | 80 (16.70%) | 234 (48.85%) | 54 (11.27%) | 111 (23.17%) | NA |
| Age (years) | 40.45 ± 10.83 | 42.53 ± 12.25 | 37.72 ± 9.02 | <0.001 | 36.69 ± 9.97a,b,c | 49.49 ± 12.02a,c,d | 30.51 ± 7.75a,b,d | 37.93 ± 9.21a,b,c | <0.001 |
| BMI (kg/m2) | 24.65 ± 3.85 | 25.12 ± 4.02 | 24.04 ± 3.31 | <0.001 | 21.76 ± 4.02b,c,d | 26.59 ± 3.90a,c,d | 25.35 ± 4.11a | 24.34 ± 3.45a,b | 0.55 |
| Frequency of sexual intercourse (times/four weeks) | 5.73 ± 2.90 | 5.41 ± 2.94 | 6.15 ± 2.30 | <0.001 | 4.45 ± 2.51b,c | 5.82 ± 2.72a,c,d | 6.16 ± 3.05a,b,d | 4.88 ± 2.88a,b,c | <0.001 |
| Duration of PE complaint (months) | 2.31 ± 1.55 | 2.31 ± 1.55 | NA | NA | 0.82 ± 0.30b,c,d | 3.35 ± 1.27a,c,d | 1.27 ± 1.01a,b,d | 1.69 ± 0.74a,b,c | <0.001 |
| Self-estimated IELT (minutes) | 2.85 ± 1.54 | 2.23 ± 1.29 | 3.65 ± 1.82 | <0.001 | 1.10 ± 0.63b,c,d | 1.86 ± 0.94a,c,d | 2.83 ± 1.52a,b,d | 3.55 ± 1.42a,b,c | <0.001 |
| Smoking, | 511 (60.55%) | 312 (65.14%) | 199 (54.52%) | 0.002 | 43 (53.75%) | 189 (80.77%) | 28 (51.85%) | 52 (46.85) | <0.001 |
| Exercise, | 403 (47.75%) | 201 (41.96%) | 202 (55.34%) | <0.001 | 32 (40.00%) | 79 (33.76%) | 29 (53.70%) | 61 (54.95%) | <0.001 |
| Educational status, | 0.118 | <0.001 | |||||||
| High school or less | 267 (31.64%) | 162 (33.82%) | 105 (28.77%) | 22 (27.50%) | 78 (33.33%) | 22 (40.74%) | 40 (36.04%) | ||
| Higher education | 577 (68.36%) | 317 (66.18%) | 260 (71.23%) | 58 (72.50%) | 156 (66.67%) | 32 (59.26%) | 71 (63.96%) | ||
| Occupational status, | 0.334 | <0.001 | |||||||
| Student | 213 (25.24%) | 130 (27.14%) | 83 (22.74%) | 16 (20.00%) | 70 (29.91%) | 12 (22.22%) | 32 (28.83%) | ||
| Employed | 456 (54.03%) | 252 (52.61%) | 204 (55.89%) | 49 (61.25) | 118 (50.43%) | 29 (53.70%) | 56 (50.45%) | ||
| Unemployed | 176 (20.85%) | 97 (20.25%) | 79 (21.64%) | 15 (18.75%) | 46 (19.66%) | 13 (24.07%) | 23 (20.72%) | ||
| Resident, | 0.345 | <0.001 | |||||||
| Urban | 389 (46.09%) | 214 (44.68%) | 175 (47.95%) | 33 (41.25%) | 104 (44.44%) | 22 (40.74%) | 55 (49.55%) | ||
| Rural | 455 (53.91%) | 265 (55.32%) | 190 (52.05%) | 47 (58.75%) | 130 (55.56%) | 32 (59.26%) | 56 (50.45%) | ||
PE = premature ejaculation; LPE = lifelong PE; APE = acquired PE; VPE = variable PE; SPE = subjective PE; NA = not applicable. Data are expressed as mean ± standard deviation or number (percentage), as appropriate. P: differences between men in PE and no PE complaint groups were assessed by the dependent t-test or chi-square test, as appropriate. P: differences among four PE syndromes were assessed by one-way analysis of variance or chi-square test, as appropriate. Differences between two PE syndromes were assessed by SNK-q test. aSignificant difference compared with LPE. bSignificant difference compared with APE. cSignificant difference compared with VPE. dSignificant difference compared with SPE.
Outcomes of the PRO, NIH-CPSI, and TCI-R questions in men with difference PE syndromes.
| Factors | Total | PE complaint | No PE complaint |
| Four PE syndromes |
| |||
|---|---|---|---|---|---|---|---|---|---|
| LPE | APE | VPE | SPE | ||||||
| PRO questions, scores | |||||||||
| Control over ejaculation | 1.68 ± 0.96 | 1.01 ± 0.82 | 2.56 ± 1.15 | <0.001 | 0.90 ± 0.72b,c,d | 0.86 ± 0.65a,c,d | 1.45 ± 0.88a,b,d | 1.17 ± 0.90a,b,c | <0.001 |
| Satisfaction with sexual intercourse | 1.69 ± 1.01 | 0.85 ± 0.75 | 2.8 ± 1.21 | <0.001 | 0.82 ± 0.64c,d | 0.80 ± 0.71c,d | 0.92 ± 0.75a,b | 0.96 ± 0.68a,b,c | <0.001 |
| Severity of PE | 2.26 ± 0.71 | 2.26 ± 0.89 | NA | NA | 2.29 ± 0.85b,c,d | 2.36 ± 1.13a,c,d | 2.05 ± 1.06a,b,d | 2.13 ± 0.79a,b,c | 0.032 |
| Personal distress | 2.04 ± 0.87 | 2.63 ± 0.93 | 1.27 ± 0.86 | <0.001 | 2.42 ± 0.67b,d | 2.65 ± 0.95a,c,d | 2.40 ± 0.65b,d | 2.84 ± 0.86a,b,c | <0.001 |
| Interpersonal difficulty | 1.85 ± 1.32 | 2.35 ± 1.54 | 1.20 ± 0.95 | <0.001 | 2.24 ± 1.32b,c,d | 2.30 ± 1.42a,d | 2.29 ± 1.40d | 2.57 ± 1.38a,b,c | 0.024 |
| NIH-CPSI question, scores | |||||||||
| Total score | 18.71 ± 4.21 | 23.12 ± 5.42 | 12.92 ± 3.50 | <0.001 | 16.72 ± 4.69b,c,d | 29.38 ± 5.73a,c,d | 13.66 ± 3.15a,b,d | 19.14 ± 4.66a,b,c | <0.001 |
| Pain score | 10.18 ± 3.46 | 12.67 ± 5.85 | 6.92 ± 2.77 | <0.001 | 7.52 ± 5.46b,c,d | 16.11 ± 4.92a,c,d | 7.54 ± 2.77a,b,d | 11.64 ± 3.32a,b,c | <0.001 |
| Urinary symptoms score | 3.52 ± 1.75 | 4.49 ± 2.02 | 2.24 ± 1.28 | <0.001 | 4.23 ± 1.81b,c,d | 5.61 ± 2.40a,c,d | 2.43 ± 1.35a,b,d | 3.31 ± 1.43a,b,c | <0.001 |
| Quality of life impact score | 5.01 ± 2.03 | 5.96 ± 2.42 | 3.76 ± 1.52 | <0.001 | 4.97 ± 2.34b,c,d | 7.66 ± 3.56a,c,d | 3.69 ± 1.28a,b,d | 4.19 ± 2.68a,b,c | <0.001 |
| TCI-R question: temperament inventory, scores | |||||||||
| Novelty seeking | 93.97 ± 11.34 | 92.01 ± 12.03 | 96.53 ± 10.21 | <0.001 | 90.28 ± 9.73b,c,d | 93.35 ± 11.08a,c,d | 91.12 ± 10.45a,b,d | 90.88 ± 8.83a,b,c | <0.001 |
| Harm avoidance | 94.85 ± 11.57 | 97.00 ± 12.44 | 92.04 ± 11.27 | <0.001 | 98.02 ± 13.29b,c,d | 97.21 ± 11.59a,c,d | 99.78 ± 14.07a,b,d | 94.45 ± 10.29a,b,c | <0.001 |
| Reward dependence | 94.77 ± 10.92 | 94.58 ± 10.82 | 95.02 ± 11.33 | 0.475 | 94.90 ± 10.80 | 93.82 ± 10.65 | 95.43 ± 11.26 | 95.52 ± 10.84 | 0.462 |
| Persistence | 126.42 ± 13.88 | 127.13 ± 13.68 | 125.49 ± 14.59 | 0.483 | 129.20 ± 14.62 | 125.83 ± 12.09 | 127.56 ± 13.30 | 128.19 ± 14.67 | 0.454 |
| TCI-R question: character inventory, scores | |||||||||
| Self-directedness | 134.26 ± 18.05 | 135.07 ± 18.85 | 133.20 ± 17.42 | 0.415 | 134.35 ± 19.01 | 135.27 ± 18.54 | 135.62 ± 19.27 | 134.89 ± 18.16 | 0.582 |
| Cooperativeness | 128.62 ± 17.80 | 129.15 ± 18.04 | 127.92 ± 17.71 | 0.665 | 128.52 ± 18.26 | 129.76 ± 18.03 | 127.15 ± 17.39 | 129.30 ± 19.32 | 0.620 |
| Self-transcendence | 70.15 ± 15.67 | 68.40 ± 15.23 | 72.43 ± 16.69 | <0.001 | 67.08 ± 13.72b,c,d | 70.03 ± 16.21a,b,d | 67.71 ± 15.86a,b,d | 66.27 ± 14.57a,b,c | <0.001 |
PRO = patient-reported outcome; NIH-CPSI = National Institutes of Health Chronic Prostatitis Symptom Index; TCI-R = Temperament and Character Inventory-Revised; PE = premature ejaculation; LPE = lifelong PE; APE = acquired PE; VPE = variable PE; SPE = subjective PE; IELT = intravaginal ejaculatory latency time; NA = not applicable. Data are expressed as mean ± standard deviation. P: differences between men in PE and no PE complaint groups were assessed by the dependent t-test or chi-square test, as appropriate. P: differences among four PE syndromes were assessed by one-way analysis of variance or chi-square test, as appropriate. Differences between two PE syndromes were assessed by SNK-q test. aSignificant difference compared with LPE. bSignificant difference compared with APE. cSignificant difference compared with VPE. dSignificant difference compared with SPE.
Figure 3Mean scores of NS/TI, HA/TI, and ST/CI in different severity of pain and urinary symptoms.
Correlations between the outcome of PRO, NIH-CPSI, and TCI-R questionnaires in men with PE complaints.
| TCI-R: temperament inventory | TCI-R: character inventory | |||||
|---|---|---|---|---|---|---|
| Novelty seeking | Harm avoidance | Self-transcendence | ||||
| Adjusted |
| Adjusted |
| Adjusted |
| |
| PRO questions, scores | ||||||
| Control over ejaculation | 0.35 | <0.001 | ||||
| Satisfaction with sexual intercourse | 0.42 | <0.001 | 0.70 | <0.001 | ||
| Severity of PE | 0.68 | <0.001 | ||||
| Personal distress | -0.62 | <0.001 | 0.60 | <0.001 | -0.48 | <0.001 |
| Interpersonal difficulty | 0.52 | <0.001 | -0.55 | <0.001 | ||
| NIH-CPSI question, scores | ||||||
| Total score | -0.55 | <0.001 | 0.60 | <0.001 | -0.43 | <0.001 |
| Pain score | -0.50 | <0.001 | 0.62 | <0.001 | -0.40 | <0.001 |
| Urinary symptoms score | 0.66 | <0.001 | ||||
| Quality of life impact score | -0.64 | <0.001 | 0.56 | <0.001 | -0.69 | <0.001 |
PRO = patient-reported outcome; NIH-CPSI = National Institutes of Health Chronic Prostatitis Symptom Index; PE = premature ejaculation; TCI-R = Temperament and Character Inventory-Revised. Correlations between the outcomes of PRO, NIH-CPSI, and TCI-R questionnaires were analyzed by partial correlations.
Correlations between the outcomes of NIH-CPSI and TCI-R questionnaires in men with different PE syndromes.
| TCI-R: temperament inventory | TCI-R: character inventory | |||||
|---|---|---|---|---|---|---|
| Novelty seeking | Harm avoidance | Self-transcendence | ||||
| Adjusted |
| Adjusted |
| Adjusted |
| |
| Total scores of NIH-CPSI | ||||||
| LPE | -0.34 | <0.001 | 0.42 | <0.001 | -0.43 | <0.001 |
| APE | -0.70 | <0.001 | 0.68 | <0.001 | -0.56 | <0.001 |
| VPE | -0.44 | <0.001 | 0.36 | <0.001 | -0.40 | <0.001 |
| SPE | -0.52 | <0.001 | 0.40 | <0.001 | -0.65 | <0.001 |
NIH-CPSI = National Institutes of Health Chronic Prostatitis Symptom Index; PE = premature ejaculation; TCI-R = Temperament and Character Inventory-Revised. Correlations between the outcomes of NIH-CPSI and TCI-R questionnaires were analyzed by partial correlations.